Optimal preoperative neoadjuvant therapy for resectable locally advanced esophageal squamous cell carcinoma-Reference-Cited by-同舟云学术

Optimal preoperative neoadjuvant therapy for resectable locally advanced esophageal squamous cell carcinoma

Published:2020-10-16 Issue:1 Volume:1482 Page:213-224
ISSN:0077-8923
Container-title:Annals of the New York Academy of Sciences
language:en
Short-container-title:Ann. N.Y. Acad. Sci.

Author:

Leng Xue‐Feng¹,Daiko Hiroyuki²,Han Yong‐Tao¹,Mao You‐Sheng³

Affiliation:

1. Division of Thoracic Surgery Sichuan Cancer Hospital & Research Institute, School of Medicine, University of Electronic Science and Technology of China (UESTC) Chengdu China

2. Department of Esophageal Surgery National Cancer Center Hospital Tokyo Japan

3. Department of Thoracic Surgery National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences & Peking Union Medical College Beijing China

Publisher

Wiley

Subject

History and Philosophy of Science,General Biochemistry, Genetics and Molecular Biology,General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/nyas.14508

Reference60 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Oesophageal carcinoma

3. Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal Cancer

4. Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial

5. Neoadjuvant Chemoradiotherapy Followed by Surgery Versus Surgery Alone for Locally Advanced Squamous Cell Carcinoma of the Esophagus (NEOCRTEC5010): A Phase III Multicenter, Randomized, Open-Label Clinical Trial

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Changes in the recent three decades and survey on the current status of surgical treatment for esophageal cancer in China;Thoracic Cancer;2024-07-19

2. Neoadjuvant immunochemotherapy improves clinical outcomes of patients with esophageal cancer by mediating anti-tumor immunity of CD8+ T (Tc1) and CD16+ NK cells;Frontiers in Immunology;2024-07-15

3. The Systemic Immune-Inflammation Index as an Independent Predictor of Survival in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma Undergoing Neoadjuvant Radiotherapy;Journal of Inflammation Research;2024-07

4. The anti-tumor activity of tangeretin in esophageal squamous cell carcinoma by inhibiting GLI2-mediated transcription of GPNMB;PLOS ONE;2024-06-26

5. IKBIP promotes tumor development via the akt signaling pathway in esophageal squamous cell carcinoma;BMC Cancer;2024-06-24